Vés al contingut

AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3,RANDOMIZED, DOUBLE-BLIND, 3-ARM STUDY TO INVESTIGATE IBUZATRELVIR INADULTS WITH SYMPTOMATIC COVID-19 WHO ARE SEVERELYIMMUNOCOMPROMISED

Obert
  • Codi protocol: C5091018
  • Codi EudraCT: No aplica
  • Grup de recerca: Malalties Infeccioses
  • Servei: Infeccioses
  • Investigador/a principal:  Len Abad, Oscar
  • Malaltia: Certes malalties infeccioses i parasitàries
  • Fase: Fase III